Orion Oyj is a Finnish pharmaceutical company committed to developing and providing innovative products in the healthcare sector, primarily focusing on pharmaceuticals and active pharmaceutical ingredients (APIs).
The company operates globally and…
Analysis
Middle-of-the-road
Orion Oyj sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is fair. The owner-earnings multiple stands at 19.0×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 6% a year, against analyst forecasts of 14%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is sturdy. The company scores 20/20 on our value-creation score: strong value creator.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202342
78
2023202420252026
All-time high
84
Jan 2025
All-time low
6
Aug 2023
Average rank
54
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
40
15
26
42
Price/Earnings
34
27
27
39
Price/Book
14
8
8
22
Dividend Yield
73
80
92
96
Value (overall)
35
27
34
35
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.